Case Report
Guillain–Barré Syndrome Associated with COVID-19 in a Japanese Male
Table 1
Results of the nerve conduction studies during the clinical course.
| | | Distal latency (ms) | CMAP distal (mV) | CMAP proximal (mV) | MCV (m/s) | F-wave minimal latency (ms) | SNAP (uV) | SCV (m/s) |
| | Median L | | Day 2 | 6.26 | 6.16 | 2.25 | 38.5 | NA | 21.90 | 25.6 | | Day 14 | 3.8 | 8.8 | 8.8 | 38.0 | 34.9 | 13.8 | 48.2 | | Day 48 | 4.1 | 15.4 | 14.8 | 51.4 | 30.9 | 15.5 | 60.0 |
| | Ulnar L | | Day 2 | 4.04 | 6.15 | 3.14 | 42.8 | NA | NA | NA | | Day 14 | 2.8 | 9.2 | 5.9 | 55.8 | 37.3 | 17.3 | 53.6 | | Day 48 | 2.9 | 11.8 | 11.2 | 54.1 | 32.0 | 21.5 | 55.6 |
| | Tibial L | | Day 14 | 4.4 | 11.0 | 4.5 | 34.1 | 61.4 | | | | Day 48 | 3.3 | 18.6 | 12.2 | 45.4 | 53.7 | | |
| | Sural L | | Day 2 | | | | | | 10.70 | 31.2 | | Day 14 | | | | | | 7.9 | 45.8 | | Day 48 | | | | | | 8.4 | 50.0 |
|
|
Abbreviations: L, left; CMAP, compound motor action potential; MCV, motor conduction velocity; SNAP, sensory nerve action potential; SCV, sensory conduction velocity; NA, not available.
|
